Table 1 Haplogroup distribution of Ashkenazi (Ash) T2DM patients who developed complications and those who did not develop any complications for at least 10 years after diagnosis ("No complications"). Patients included in this table may have more than one complication. N – number of patients in each group; (%) – percentage of patients belonging to a certain haplogroup in a specific group.
Haplogroup | All Ash N (%) | No complications N (%) | Cardiovascular N (%) | Retino-pathy N (%) | Nephro-pathy N (%) |
|---|---|---|---|---|---|
U (nonK) | 51 (6.7) | 19 (7.1) | 12 (4.6) | 9 (7.6) | 22 (7.1) |
K1 | 178 (23.4) | 56 (21) | 65 (24.9) | 25 (21.2) | 77 (25) |
K2 | 44 (5.8) | 17 (6.4) | 14 (5.4) | 6 (5.1) | 19 (6.2) |
1HV* | 74 (9.7) | 26 (9.7) | 27 (10.3) | 14 (11.9) | 25 (8.1) |
H | 175 (23) | 60 (22.5) | 66 (25.3) | 31 (26.3) | 73 (23.7) |
J1 | 59 (7.8) | 14 (5.2) | 18 (6.9) | 14 (11.9) | 33 (10.7) |
T | 33 (4.3) | 13 (4.9) | 9 (3.4) | 3 (2.5) | 12 (3.9) |
N1b | 44 (5.8) | 23 (8.6) | 13 (5) | 6 (5.1) | 9 (2.9) |
IWX | 31 (4.1) | 12 (4.5) | 8 (3.1) | 2 (1.7) | 16 (5.2) |
2Others | 71 (9.3) | 27 (10.1) | 29 (11.1) | 8 (6.8) | 22 (7.1) |
Total | 760** | 267** | 261 | 118 | 308 |